Note: Ingredients listed on restricted chemical lists
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
557-04-0
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2015-09-13
Product name
NINLARO Capsules 2.3, 3.0, 4.0mg
Product Synonyms
Ixazomib
1.2.1 Relevant identified uses
Pharmaceutical Product
1.2.2. Uses advised against
All other uses
Manufacturer Name
Takeda Pharmaceuticals International Company
Icons in SDS
Company Information
company name
Takeda Pharmaceuticals International Company
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H361, H372
Hazard statements
Code
Statements
H300
Fatal if swallowed
H361
Suspected of damaging fertility or the unborn child
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
Classification according to GHS
Physical Health
Environmental hazards
Not Hazardous Acute Oral Toxicity Category 2 (H300) Not Hazardous Reproductive Toxicity Category 2 (H361) Specific Target Organ Toxicity Repeat Dose Category 1 (H372)
Signal word
DANGER
Hazard statements
H300 Fatal if swallowed. H361 Suspected of damaging fertility or the unborn child. H372 Causes damage to lymphoid tissue, bone marrow, gastrointestinal tract and nervous system through prolonged or repeated exposure.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust P264 Wash exposed skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor. P330 Rinse mouth. P308 + P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up. P501 Dispose of contents and container in accordance with local and national regulations.